Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02709824
Other study ID # ADS2012
Secondary ID
Status Completed
Phase N/A
First received March 11, 2016
Last updated March 11, 2016
Start date December 2011
Est. completion date July 2012

Study information

Verified date March 2016
Source University of Milan
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

Dental staining is the most common local side effect of chlorhexidine (CHX) mouthwashes.

A prospective, cross-over, randomized clinical trial will be carried out in triple blind to compare the effect on dental staining of two 0.12% CHX mouthwashes: with or without ADS. Twenty-two healthy subjects will be enrolled. Briefly, the study includes two sequential stages: in the first phase, we record the "immediate" objective and subjective evaluation of dental discoloration by spectroscopic and questionnaire-based analyses, at baselines and after each 21 days long-cycle of mouthwash. A wash-out period between the cycles of 21 days is performed.

In the second phase, a long-term (after 6 months) subjective evaluation of dental discoloration was obtained by means of clinical photograph visual analysis and new questionnaires.


Description:

In the first phase, we will record the "immediate" objective and subjective evaluation of dental discoloration by spectroscopic (CIE L*a*b* data analysis with DeltaE evaluation) and questionnaire-based analyses. Immediate visual analysis of tooth pigmentation will be evaluated by volunteer him/herself, using a mirror, and by a single dentist soon after the end of each treatment. They will indicate the presence/absence of dental pigmentation, and to quantify it with a numeric scale (0= no pigmentation to 10= very strong pigmentation).

These analyses will be performed at baselines and after each 21 days long-cycle of mouthwash.

A wash-out period between the cycles of 21 days will be performed. In the second "late" phase, a long-term subjective evaluation of dental discoloration will be obtained by means of clinical photograph visual analysis and new questionnaires. After 6 months from clinical trial (second stage of the study), frontal dental photographs of volunteers, collected during the first phase, will be printed on photographic paper and, then, visually analyzed, in blind, by the 22 volunteers themselves, 14 dentists and 13 oral hygienists ad hoc recruited. Dentists and oral hygienists, in particular, will be asked to observe two images of all the 22 subjects, i.e. after treatment with A or B mouthwash, and to answer to the question: "Which picture shows the most pigmented teeth?" Possible answers will be: "A, or B or no difference between the two images". Pigmentation will be also quantified using the numeric scale (0= no pigmentation to 10=strong pigmentation).

The observer will be not instructed in how the color of the teeth should appear in case of CHX pigmentation.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date July 2012
Est. primary completion date February 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- a subject had to be free from oral mucosa conditions affecting its integrity and to avoid drug or mouthwash intake during the study and in the previous month (eligibility criteria).

Exclusion Criteria:

- specific allergy to mouthrinses, presence of periodontitis, and frequent use of CHX-based oral hygiene products.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)


Related Conditions & MeSH terms


Intervention

Drug:
Chlorhexidine gluconate with ADS
Oral rinsing, twice a day, for 21 days
Chlorhexidine gluconate without ADS
Oral rinsing, twice a day, for 21 days

Locations

Country Name City State
Italy University of Milan Milano

Sponsors (1)

Lead Sponsor Collaborator
University of Milan

Country where clinical trial is conducted

Italy, 

References & Publications (4)

Bernardi F, Pincelli MR, Carloni S, Gatto MR, Montebugnoli L. Chlorhexidine with an Anti Discoloration System. A comparative study. Int J Dent Hyg. 2004 Aug;2(3):122-6. — View Citation

Cortellini P, Labriola A, Zambelli R, Prato GP, Nieri M, Tonetti MS. Chlorhexidine with an anti discoloration system after periodontal flap surgery: a cross-over, randomized, triple-blind clinical trial. J Clin Periodontol. 2008 Jul;35(7):614-20. doi: 10.1111/j.1600-051X.2008.01238.x. Epub 2008 Apr 16. — View Citation

Li W, Wang RE, Finger M, Lang NP. Evaluation of the antigingivitis effect of a chlorhexidine mouthwash with or without an antidiscoloration system compared to placebo during experimental gingivitis. J Investig Clin Dent. 2014 Feb;5(1):15-22. doi: 10.1111/jicd.12050. Epub 2013 Jun 14. — View Citation

Solís C, Santos A, Nart J, Violant D. 0.2% chlorhexidine mouthwash with an antidiscoloration system versus 0.2% chlorhexidine mouthwash: a prospective clinical comparative study. J Periodontol. 2011 Jan;82(1):80-5. doi: 10.1902/jop.2010.100289. Epub 2010 Jul 27. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Dental Staining - spectroscopic evaluation dental color before and after the two treatments 21 days No
Secondary Dental Staining - visual evaluation dental color before and after the two treatments 21 days No
Secondary Dental Staining - visual evaluation on images dental color before and after the two treatments 21 days of treatments, re-analysis of images after 6 months from the end of the trial No
See also
  Status Clinical Trial Phase
Completed NCT05035888 - Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia Hypotension N/A
Completed NCT04028791 - Sickle Cell Trait and Exercise, Effect of Hot Environment N/A
Completed NCT04556357 - Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia N/A
Completed NCT04118322 - The Effect of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy N/A
Recruiting NCT03456544 - Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
Completed NCT03723109 - Airway Management During TCI vs RSI Anesthesia Induction
Completed NCT03316417 - Study of Adverse Renal Effects of Immune Checkpoints Inhibitors
Completed NCT05712018 - Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine N/A
Not yet recruiting NCT04576663 - Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia N/A
Completed NCT03006042 - Pharmacokinetics of BPV Following Bilateral US-guided TAP Block for C-section N/A
Completed NCT03011775 - Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease Phase 4
Completed NCT04556370 - Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia. N/A
Completed NCT03706755 - Comparison of Two Doses of Norepinephrine in Preventing Hypotension After Spinal Anesthesia Phase 4
Completed NCT02768168 - The Effects of Dezocine Pretreatment on Dexamethasone Induced Perineal Irritation N/A
Completed NCT02854787 - Intravenous Bolus of Phenylephrine vs. Norepinephrine in Preventing Hypotension After Spinal Anesthesia Phase 4
Completed NCT04272567 - Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension N/A
Recruiting NCT05310331 - Donafenib for Recurrent Cervical Cancer Phase 2
Completed NCT05690334 - Different Crystalloid Coload Volumes on the 90% ED of Norepinephrine N/A
Not yet recruiting NCT06467045 - Frequency of Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging
Completed NCT05475873 - Ondansetron for Postspinal Anesthesia Hypotension N/A